<?xml version="1.0"?>
<Articles JournalTitle="Immunology and Genetics Journal">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>8</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>24</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Breast Cancer-Associated Fibroblasts Could Induce the PI3K/Akt/mTOR Signaling Pathway Through Downstream Long Non-Coding RNA HOTAIR</title>
    <FirstPage>111</FirstPage>
    <LastPage>123</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Sadeghalvad</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid-Reza</FirstName>
        <LastName>Mohammadi-Motlagh</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kamran</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Mostafaie</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Noorbakhsh</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sadaf</FirstName>
        <LastName>Alipour</LastName>
        <affiliation locale="en_US">Breast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Surgery, Arash Women&#x2019;s Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Foroozan</FirstName>
        <LastName>Ghalkhani</LastName>
        <affiliation locale="en_US">Imam Reza Hospital, AJA University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ramesh</FirstName>
        <LastName>Omranipour</LastName>
        <affiliation locale="en_US">Breast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seid-Shahram</FirstName>
        <LastName>Miraghaee</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sarah</FirstName>
        <LastName>Kiani</LastName>
        <affiliation locale="en_US">Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Immunodeficiencies, Children&#x2019;s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Cancer-associated fibroblasts (CAFs) play an important role in the initiation and progression of tumor cells. These cells can trigger signaling pathways involved in tumor progression. HOTAIR, an increased long non-coding RNA (lncRNA) in breast cancer, has a vital role in the tumorigenesis and development of breast cancer cells. 
&#xD;

Methods: In this study, a fibroblast cell culture medium was used to investigate its possible role in inducing the HOTAIR expression and PI3K/Akt/mTOR pathway in breast cancer cells. CAFs and normal fibroblasts (NFs) were isolated from tumors of 6 patients with breast cancer and subjects with healthy breasts, respectively. The MCF-7 cells were cultured in a medium obtained from CAFs (CAF-CM) or NFs (NF-CM), and then the expression of HOTAIR and PI3K/Akt/mTOR in MCF-7 cells was assessed using Real-Time PCR. HOTAIR was silenced in MCF-7 cells using siRNAs and then cultured in CAF-CM or NF-CM. Subsequently, the phosphorylation status of PI3K/Akt/mTOR proteins was analyzed by western blotting. 
&#xD;

Results: Fibroblast culture medium enhanced the expression of HOTAIR and activation of the PI3K/Akt/mTOR pathway in breast cancer cells. By HOTAIR silencing, reduced activity of the PI3K/Akt/mTOR pathway, as well as the lower effect of fibroblast culture medium in the induction of PI3K/Akt/mTOR pathway, was seen. 
&#xD;

Conclusion: HOTAIR can play a role as a mediator in inducing the PI3K/Akt/mTOR pathway in breast cancer cells by the effect of cancer-associated fibroblast cells.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/196</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/196/173</pdf_url>
  </Article>
</Articles>
